Compare MYSE & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYSE | PTHL |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 8.8M |
| IPO Year | 2021 | 2024 |
| Metric | MYSE | PTHL |
|---|---|---|
| Price | $2.65 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.6K | ★ 104.8K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $581.00 | ★ $448,196.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.82 | N/A |
| 52 Week Low | $1.61 | $0.47 |
| 52 Week High | $9.34 | $32.00 |
| Indicator | MYSE | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 37.99 |
| Support Level | $2.30 | $0.50 |
| Resistance Level | $2.72 | $0.63 |
| Average True Range (ATR) | 0.21 | 0.05 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 93.58 | 31.51 |
Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.